Related Product Information for Rapid RCA assay kit
Background/Introduction: Recombinant adenoviruses have tremendous potential in both research and therapeutic applications. They provide numerous advantages when introducing genetic material into host cells. The permissive host cell range is very wide. Adenovirus has been used to infect many mammalian cell types (both replicative and non-replicative) for high expression of the recombinant protein. Recombinant adenoviruses are especially useful for gene transfer and protein expression in cell lines that have low transfection efficiency with liposome. After entering cells, the virus remains epichromosomal (i.e. does not integrate into the host chromosome so does not activate or inactivate host genes). Recently, recombinant adenoviruses have been used to deliver RNAi into cells. HEK 293 cells or their variants are used as host cells for viral amplification. Recombinant adenoviruses can be grown at high titer, e.g. 1010 VP (viral particles)/mL, which can be concentrated up to 1013 VP/mL, and subsequently purified by ViraBind™ Adenoviral Purification Kit or traditional CsCl ultracentrifugation. During adenovirus vector production, particles may be generated which are replication competent. The probability of producing replication competent adenovirus (RCA), although low, increases with each successive amplification. RCA is thought to be produced via homologous recombination. Traditionally, RCA is measured in permissive cells by a plaque-forming unit (PFU) assay that scores the number of viral plaques as a function of dilution. These methods are time-consuming (10-14 days), require a long infection period, and suffer from a high degree of inter-assay variability and are affected by virus-cell interactions. Rapid RCA Assay Kit utilizes an antibody against adenovirus hexon proteins to visualize infected cells by immunocytochemistry staining, the kit antibody against hexon protein recognizes all serotypes of adenovirus. The hexon proteins are the largest and most abundant of the structural proteins in the adenovirus capsid, and they are distributed symmetrically to form capsid facets. Rapid RCA Assay Kit provides a quick and complete system to measure the titer of replication-competent virus in your viral prep. In contrast to the 10-day infection of a classical plaque assay, the kit only requires 2-day infection. The kit provides sufficient reagents for up to 30 tests in 6-well culture plates.
Product Categories/Family for Rapid RCA assay kit
References
1. Bewig, B., and W. E. Schmidt (2000) Accelerated titering of adenoviruses. BioTechniques 28:870-873.
Dubuisson, O. et al. (2015). Accurate identification of neutralizing antibodies to adenovirus Ad36, a putative contributor of obesity in humans. J Diabetes Complications. 29: 83-87.
Product Notes
The Rapid RCA (Catalog #
AAA168025) is an Assay Kit and is intended for research purposes only. The product is available for immediate purchase.
It is sometimes possible for the material contained within the vial of
"Rapid RCA, Assay Kit" to become dispersed throughout the inside of
the vial, particularly around the seal of said vial, during shipment and storage. We always
suggest centrifuging these vials
to consolidate all of the liquid away from the lid and to the bottom of the vial prior to
opening. Please be advised that
certain products may require dry ice for shipping and that, if this is the case, an
additional dry ice fee may also be
required.
Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are
absolutely not suitable for use in any
sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a
product from AAA Biotech, you
are explicitly certifying that said products will be properly tested and used in line with
industry standard. AAA Biotech
and its authorized distribution partners reserve the right to refuse to fulfill any order if
we have any indication that a
purchaser may be intending to use a product outside of our accepted criteria.
Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech
cannot be held
responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any
aspect of this datasheet at
any time and without notice. It is the responsibility of the customer to inform AAA Biotech
of any product performance
issues observed or experienced within 30 days of receipt of said product. To see additional
details on this or any of our
other policies, please see our
Terms & Conditions page.